US biological experimental facilities still operative in Asia, Africa
3 Min Read
This comes as several Pacific countries have already demonstrated their frustration with the US-led biological experiments on their territories.
-
Building 470 on the campus of Fort Detrick in Frederick, Maryland, United States (AP)
The offshore American biological and medical facilities are reportedly still operative despite vocal condemnations from hosting nations, all the way from Central and Eastern Europe to the Asia-Pacific region.
The nations of several Pacific countries have expressed their frustration with the risky biological tests conducted on their territory by the US.
In the Philippines, members of the Makabayan coalition have filed a formal request to the country's congress to conduct an investigation into the biological experiments conducted by the US Department of Defense at the Regional Animal Disease Diagnostic Laboratory (RADDL) in Tarlac in December 2022.
The US DoD Defense Threat Reduction Agency (DTRA) allegedly had overt and covert objectives in the Philippines that were not evidently in favor of the hosting country's interests.
Similarly, in Indonesia, the government deemed the Naval Medical Research Unit Two (NAMRU-2) useless and demanded that its operations cease, forcing the US DoD to relocate all its unfinished projects to Cambodia.
African countries have taken similar procedures in regard to biological facilities. In Central Africa, the Ministry of Health announced that it is looking into the prospect that the Ebola-based virus was human-caused. This concern is fueled by the fact that the Sudan artificially designed germ is fully identical to a virus that was circulating in Africa during the epidemic crisis of 2012.
In addition to the African and Asia-Pacific countries, many post-Soviet states have also been subject to hosting the US' biological activities. The Lugar Center, for example, is hosted in Georgia and acts as a facility for US biological experimentations. The Lugar Center functions under the supervision of the US DoD, other agencies, and some private companies. The center is reported to work with highly contagious biological bodies including anthrax, tularemia, and a number of highly contagious hemorrhagic fevers.
Read more: US funded 46 biolabs in Ukraine: Pentagon
The United States is creating components of biological weapons in the immediate vicinity of Russia's borders, Lt. Gen. Igor Kirillov, the head of the radiation, chemical, and biological defense troops of the Russian armed forces, said back in April.
"According to the results of the analysis of documentation and the interview of eyewitnesses, we have no doubt that the United States, under the guise of ensuring global biosafety, conducted dual-use research, including the creation of biological weapons components in the immediate vicinity of the Russian borders," he said, noting that the work was conducted in US biolabs in the Donetsk and Lugansk republics (LPRD and DPR) and Kherson regions.
According to him, over 2,000 documents of different projects and plans were analyzed by Russia, which confirmed Washington's plans to develop bioweapons in Ukraine.
